Agentiiv enters strategic technology partnership with the Vector Institute

Agentiiv – a pioneer in enterprise-grade, agentic AI systems in Canada – today announced a technology partnership with the Vector Institute. As a Vector technology partner, Agentiiv gains access to ...
Seeking Alpha

Regenxbio's Vector Technology Will Change Gene Therapy

Regenxbio has a competitive advantage in the market with its proprietary NAV technology platform, based on AAV vectors, that is highly effective, efficient, and scalable. The recent Phase II trial on ...

Vector Expands Timing Analysis Expertise Through RocqStat Acquisition

Vector Informatik, a leading solution provider for software-defined systems in automotive and beyond, has acquired the RocqStat software technology and the expert team from StatInf. This acquisition ...
GEN

Advancing Viral Vector-Based Technology

Introgen Therapeutic’s (Austin, TX) p53-based INGN 225 cancer vaccine yielded promising safety and efficacy results in a Phase II trial in advanced small cell lung cancer. The personalized therapeutic ...
New Electronics

Vector strengthens timing analysis portfolio with RocqStat acquisition

Vector Informatik has acquired the RocqStat software technology and specialist team from StatInf, expanding its capabilities ...
Nasdaq

FDA Grants Platform Technology Status To Sarepta's RAAVrh74 Vector

(RTTNews) - Sarepta Therapeutics (SRPT), Wednesday announced that the FDA has designated its rAAVrh74 viral vector used in the investigational gene therapy SRP-9003 for limb-girdle muscular dystrophy ...
GEN

Vector Production Would Benefit from Purpose-Built Processing Technology

Demand for lentiviral vectors will continue to outstrip supply until the industry has access to more efficient, purpose-built manufacturing and bioprocessing technologies. The warning comes from ...